Literature DB >> 23932487

Inter-observer reproducibility of semi-automatic tumor diameter measurement and volumetric analysis in patients with lung cancer.

J Dinkel1, O Khalilzadeh, C Hintze, M Fabel, M Puderbach, M Eichinger, H-P Schlemmer, M Thorn, C P Heussel, M Thomas, H-U Kauczor, J Biederer.   

Abstract

OBJECTIVES: Therapy monitoring in oncologic patient requires precise measurement methods. In order to improve the precision of measurements, we used a semi-automated generic segmentation algorithm to measure the size of large lung cancer tumors. The reproducibility of computer-assisted measurements were assessed and compared with manual measurements.
METHODS: CT scans of 24 consecutive lung cancer patients who were referred to our hospital over a period of 6 months were analyzed. The tumor sizes were measured manually by 3 independent radiologists, according to World Health Organization (WHO) and the Revised Response Evaluation Criteria in Solid Tumors (RECIST) guidelines. At least 10 months later, measurements were repeated semi-automatically on the same scans by the same radiologists. The inter-observer reproducibility of all measurements was assessed and compared between manual and semi-automated measurements.
RESULTS: Manual measurements of the tumor longest diameter were significantly (p < 0.05) smaller compared with the semi-automated measurements. The intra-rater correlations coefficients were significantly higher for measurements of longest diameter (intra-class correlation coefficients: 0.998 vs. 0.986; p < 0.001) and area (0.995 vs. 0.988; p = 0.032) using semi-automated compared with manual method. The variation coefficient for manual measurement of the tumor area (WHO guideline, 15.7% vs. 7.3%) and the longest diameter (RECIST guideline, 7.7% vs. 2.7%) was 2-3 times that of semi-automated measurement.
CONCLUSIONS: By using computer-assisted size assessment in primary lung tumor, interobserver-variability can be reduced to about half to one-third compared to standard manual measurements. This indicates a high potential value for therapy monitoring in lung cancer patients.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Inter-rater reliability; Lung cancer; RECIST guideline; Tumor size; Volumetric analysis; WHO guideline

Mesh:

Year:  2013        PMID: 23932487     DOI: 10.1016/j.lungcan.2013.07.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  14 in total

1.  Smaller but denser: postmortem changes alter the CT characteristics of subdural hematomas.

Authors:  Nicole Berger; Lars C Ebert; Garyfalia Ampanozi; Patricia M Flach; Dominic Gascho; Michael J Thali; Thomas D Ruder
Journal:  Forensic Sci Med Pathol       Date:  2015-01-08       Impact factor: 2.007

Review 2.  From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel.

Authors:  Chunxia Su; Mathias Meyer; Robert Pirker; Wieland Voigt; Jingyun Shi; Lothar Pilz; Rudolf M Huber; Yilong Wu; Jinghong Wang; Yonglan He; Xuan Wang; Jian Zhang; Xiuyi Zhi; Meiqi Shi; Bo Zhu; Stefan S Schoenberg; Thomas Henzler; Christian Manegold; Caicun Zhou; Eric Dominic Roessner
Journal:  Transl Lung Cancer Res       Date:  2016-08

3.  Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas.

Authors:  Matthieu Peyre; Marc Zanello; Karima Mokhtari; Anne-Laure Boch; Laurent Capelle; Alexandre Carpentier; Stephane Clemenceau; Carine Karachi; Soledad Navarro; Aurelien Nouet; Vincent Reina; Charles-Ambroise Valery; Marc Sanson; Philippe Cornu; Michel Kalamarides
Journal:  J Neurooncol       Date:  2015-04-17       Impact factor: 4.130

4.  Semi-automatic 3D-volumetry of liver metastases from neuroendocrine tumors to improve combination therapy with 177Lu-DOTATOC and 90Y-DOTATOC.

Authors:  Matthaeus Cieciera; Clemens Kratochwil; Jan Moltz; Hans Ulrich Kauczor; Tim Holland Letz; Peter Choyke; Walter Mier; Uwe Haberkorn; Frederik L Giesel
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

5.  Comparison of a radiomic biomarker with volumetric analysis for decoding tumour phenotypes of lung adenocarcinoma with different disease-specific survival.

Authors:  Mei Yuan; Yu-Dong Zhang; Xue-Hui Pu; Yan Zhong; Hai Li; Jiang-Fen Wu; Tong-Fu Yu
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

6.  Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Authors:  Nicholas J Pastis; Travis J Greer; Nichole T Tanner; Amy E Wahlquist; Leonie L Gordon; Anand K Sharma; Nicholas C Koch; Gerard A Silvestri
Journal:  Chest       Date:  2014-08       Impact factor: 9.410

Review 7.  A review of automatic lung tumour segmentation in the era of 4DCT.

Authors:  Nadine Wong Yuzhen; Sarah Barrett
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-22

8.  Comparison of CT volumetric measurement with RECIST response in patients with lung cancer.

Authors:  S A Hayes; M C Pietanza; D O'Driscoll; J Zheng; C S Moskowitz; M G Kris; M S Ginsberg
Journal:  Eur J Radiol       Date:  2016-01-02       Impact factor: 3.528

9.  Do Diametric Measurements Provide Sufficient and Reliable Tumor Assessment? An Evaluation of Diametric, Areametric, and Volumetric Variability of Lung Lesion Measurements on Computerized Tomography Scans.

Authors:  Aaron Frenette; Joshua Morrell; Kirk Bjella; Edward Fogarty; James Beal; Vijay Chaudhary
Journal:  J Oncol       Date:  2015-05-10       Impact factor: 4.375

10.  Systematic analysis of measurement variability in lung cancer with multidetector computed tomography.

Authors:  Binghu Jiang; Dan Zhou; Yujie Sun; Jichen Wang
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.